Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0311277 (
abdominal obesity
)
2,792
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Obesity is one of the major risk factors of vascular diseases, and its prevalence is increasing worldwide. In the past decade, progress has been made in the understanding of genetic determinants of obesity and obesity-associated diseases. Genome-wide association studies identified a number of genetic variants associated with obesity. In addition to common variants, FTO and MC4R, new loci, such as TMEM18, KCTD15, GNPDA2, SH2B1, MTCH2, and
NEGR1
have been detected. In the past years,
abdominal obesity
has been shown to be a more important vascular risk factor than the body mass index. In the context of vascular risk assessment, identification of genetic polymorphisms associated with accumulation of visceral fat is of special importance. Some polymorphisms associated with
abdominal obesity
, such as variants of gene encoding microsomal triglyceride transfer protein, have been already discovered. In this chapter, we provide a review of genetic determinants of obesity and discuss their role in obesity-related vascular diseases.
...
PMID:Genetic determinants of obesity and related vascular diseases. 2337 11
Introduction
. Increase in body weight is a gradual process that usually begins in childhood and in adolescence as a result of multiple interactions among environmental and genetic factors. This study aimed to analyze the relationship between copy number variants (CNVs) in five genes and four intergenic regions with obesity in Mexican children.
Methods
. We studied 1423 children aged 6-12 years. Anthropometric measurements and blood levels of biochemical parameters were obtained. Identification of CNVs was performed by real-time PCR. The effect of CNVs on obesity or body composition was assessed using regression models adjusted for age, gender, and family history of obesity.
Results
. Gains in copy numbers of
LEPR
and
NEGR1
were associated with decreased body mass index (BMI), waist circumference (WC), and risk of
abdominal obesity
, whereas gain in
ARHGEF4
and
CPXCR1
and the intergenic regions 12q15c, 15q21.1a, and 22q11.21d and losses in
INS
were associated with increased BMI and WC.
Conclusion
. Our results indicate a possible contribution of CNVs in
LEPR
,
NEGR1
,
ARHGEF4
, and
CPXCR1
and the intergenic regions 12q15c, 15q21.1a, and 22q11.21d to the development of obesity, particularly
abdominal obesity
in Mexican children.
...
PMID:Copy Number Variations in Candidate Genes and Intergenic Regions Affect Body Mass Index and Abdominal Obesity in Mexican Children. 2842 59